Orthopedic medical device company with 2 new biomimetic (tissue-like) spine implants (GelStix & GelFix) entering US clinical trials. Both implants have been approved in Europe (receiving CE-mark) for use in treating chronic low back pain due to degenerative disc disease (DDD) and spinal stenosis, respectively. GelActive Spine acquired the assets from Replication Medical and is the exclusive licensee.